Buckingham Strategic Partners Caribou Biosciences, Inc. Transaction History
Buckingham Strategic Partners
- $5.48 Billion
- Q4 2024
A detailed history of Buckingham Strategic Partners transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Buckingham Strategic Partners holds 12,127 shares of CRBU stock, worth $11,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,127Holding current value
$11,399% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
138Shares Held
54.4MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$6.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$4.29 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$3.64 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$2.58 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$2.35 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $57.2M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...